Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsReceivables - NetShares Issued
Ratios

Outlook Therapeutics (OTLK) Shares Issued (2016 - 2025)

Outlook Therapeutics (OTLK) has disclosed Shares Issued for 8 consecutive years, with $14.9 million as the latest value for Q4 2025.

  • Quarterly Shares Issued rose 756.97% to $14.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $26.5 million through Dec 2025, up 49.1% year-over-year, with the annual reading at $25.4 million for FY2025, 57.91% down from the prior year.
  • Shares Issued for Q4 2025 was $14.9 million at Outlook Therapeutics, up from $8.1 million in the prior quarter.
  • The five-year high for Shares Issued was $14.9 million in Q4 2025, with the low at $1.4 million in Q1 2025.